Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study
Crossref DOI link: https://doi.org/10.1136/rmdopen-2021-001906
Published Online: 2021-11-24
Published Print: 2021-11
Update policy: https://doi.org/10.1136/crossmarkpolicy
Janssen, Marlou THF https://orcid.org/0000-0002-8280-9561
Ramiro, Sofia
Mostard, Rémy LM
Magro-Checa, Cesar
Landewé, Robert BM https://orcid.org/0000-0002-0577-6620
License valid from 2021-11-24